Research Topics
| Adrian F HernandezSummaryAffiliation: Duke University Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Contemporary performance of surgical ventricular restoration procedures: data from the Society of Thoracic Surgeons' National Cardiac DatabaseAdrian F Hernandez
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
Am Heart J 152:494-9. 2006..We sought to characterize the performance of SVR nationally and describe the acute risks of mortality and major morbidity plus predictors of adverse outcomes...
Outcomes in heart failure patients after major noncardiac surgeryAdrian F Hernandez
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
J Am Coll Cardiol 44:1446-53. 2004..The purpose of this study was to evaluate mortality and readmission rates of heart failure (HF) patients after major noncardiac surgery...
A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac DatabaseAdrian F Hernandez
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
Circulation 116:606-12. 2007..We examined a large national clinical database to assess trends in the incidence of post-cardiac surgery shock requiring VAD implantation, survival rates, and risk factors for mortality...
Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fractionAdrian F Hernandez
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
JAMA 308:2097-107. 2012..Aldosterone antagonist therapy for heart failure and reduced ejection fraction has been highly efficacious in randomized trials. However, questions remain regarding the effectiveness and safety of the therapy in clinical practice...
Relationships between emerging measures of heart failure processes of care and clinical outcomesAdrian F Hernandez
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Am Heart J 159:406-13. 2010..Previous studies have not confirmed associations between some current performance measures for inpatient heart failure processes of care and postdischarge outcomes. It is unknown if alternative measures are associated with outcomes...
Comparison of composite measure methodologies for rewarding quality of care: an analysis from the American Heart Association's Get With The Guidelines programZubin J Eapen
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
Circ Cardiovasc Qual Outcomes 4:610-8. 2011..We sought to conduct an observational analysis to determine the influence of the opportunity-based and all-or-none composite performance measures on hospital rankings...
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activatorYing Xian
Duke Clinical Research Institute, Durham, NC 27715, USA
JAMA 307:2600-8. 2012..7 or lower, there are few data on safety of intravenous tPA in warfarin-treated patients in clinical practice...
Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claimsRobb D Kociol
Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA
Clin Cardiol 34:682-8. 2011..Although pharmacologic prophylaxis regimens have reduced VTE risk in medically ill patients, associations with early postdischarge adverse clinical outcomes among patients with heart failure are unknown...
Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failureRobb D Kociol
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
Am J Cardiol 108:985-91. 2011..Strategies are needed to ensure access among vulnerable populations to this supply-sensitive resource...
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severityGregg C Fonarow
Division of Cardiology, University of California, Los Angeles, USA
JAMA 308:257-64. 2012....
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National RegistryRobb D Kociol
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Am Heart J 163:994-1001. 2012..Associations between BNP level and thromboembolic events in patients with HF without atrial fibrillation (AF) are not well studied...
Postoperative inotrope and vasopressor use following CABG: outcome data from the CAPS-care studyJudson B Williams
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
J Card Surg 26:572-8. 2011..Limited clinical data exist to guide practice patterns and evidence-based use of inotropes and vasopressors following coronary artery bypass grafting (CABG)...
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiariesAdrian F Hernandez
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
JAMA 300:2398-406. 2008..In 2003, Medicare expanded coverage of ventricular assist devices as destination, or permanent, therapy for end-stage heart failure. Little is known about the long-term outcomes and costs associated with these devices...
International variation in use of oral anticoagulation among heart failure patients with atrial fibrillationJorge Suarez
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Am Heart J 163:804-11. 2012..We sought to characterize patient factors and regional variations associated with vitamin K antagonist (VKA) use in patients with heart failure (HF) and atrial fibrillation (AF) in areas outside the United States and Europe...
Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failureRobb D Kociol
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Am J Cardiol 105:1786-93. 2010..12, 95% confidence interval 1.04 to 1.20) but not readmission or total inpatient costs. In conclusion, worsening RF in patients hospitalized with HF was independently associated with long-term mortality...
The need for multiple measures of hospital quality: results from the Get with the Guidelines-Heart Failure Registry of the American Heart AssociationAdrian F Hernandez
Duke Clinical Research Institute, Durham, NC 27715, USA
Circulation 124:712-9. 2011..Whether these quality measures correlate with one another and the degree to which hospital provider rankings shift on the basis of the performance metric is uncertain...
Quality of care for atrial fibrillation among patients hospitalized for heart failureJonathan P Piccini
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
J Am Coll Cardiol 54:1280-9. 2009..This study sought to examine quality of care and warfarin use at discharge in patients with atrial fibrillation (AF) and heart failure (HF)...
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomesBenjamin A Steinberg
Duke University Medical Center, Durham, NC, USA
Circulation 126:65-75. 2012..Heart failure with preserved ejection fraction (EF) is a common syndrome, but trends in treatments and outcomes are lacking...
Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failureLesley H Curtis
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Am Heart J 163:946-953.e1. 2012..Questions remain about its clinical effectiveness and safety for patients who are underrepresented in randomized trials and those at risk for hyperkalemia...
Predicting costs among medicare beneficiaries with heart failureMelissa A Greiner
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
Am J Cardiol 109:705-11. 2012..In conclusion, a model based on variables from clinical registries can identify a group of patients with heart failure who on average will incur higher costs in the first year after hospitalization...
Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?Sana M Al-Khatib
MHS, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Circulation 125:1094-101. 2012..The degree to which the overall use of ICD therapy and disparities in use have changed is unclear...
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failureAdrian F Hernandez
Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
Circ Heart Fail 3:7-13. 2010..The clinical effectiveness of implantable cardioverter-defibrillators (ICDs) in older patients with heart failure has not been established, and older patients have been underrepresented in previous studies...
Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claimsRobb D Kociol
Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
Circ Heart Fail 4:628-36. 2011..It is unknown if admission, discharge, or change from admission to discharge BNP measure is the most important predictor of long-term outcomes...
Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registryRyenn West
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Eur J Heart Fail 13:945-52. 2011..To characterize geographic differences in clinical characteristics and care of patients hospitalized with heart failure and preserved ejection fraction (HF-PEF)...
Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program)Amrut V Ambardekar
Division of Cardiology, Denver Health Medical Center, The University of Colorado at Denver and the Health Sciences Center, Denver, Colorado, USA
Am J Cardiol 105:139-43. 2010..87 to 1.26). In conclusion, within the GWTG-CAD quality improvement initiative, patients with CAD treated at rural hospitals receive similar quality of care and have similar outcomes as those at urban centers...
The importance of consistent, high-quality acute myocardial infarction and heart failure care results from the American Heart Association's Get with the Guidelines ProgramTracy Y Wang
Duke Clinical Research Institute, Durham, North Carolina, USA
J Am Coll Cardiol 58:637-44. 2011..This study examined the degree to which hospital performance for acute myocardial infarction (AMI) and heart failure (HF) care processes are correlated...
Use of guideline-recommended therapies for heart failure in the Medicare populationLisa D DiMartino
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
Clin Cardiol 33:400-5. 2010..Most information about the use of guideline-recommended therapies for heart failure reflects what occurred at discharge after an inpatient stay...
Non-evidence-based ICD implantations in the United StatesSana M Al-Khatib
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
JAMA 305:43-9. 2011....
Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalizationBradley G Hammill
Duke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA
Circ Cardiovasc Qual Outcomes 4:60-7. 2011..As clinical data become more readily available, the incremental value of adding clinical data to claims-based models of mortality and readmission is unclear...
Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation auditYing Xian
Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 163:392-8, 398.e1. 2012..Get With The Guidelines (GWTG)-Stroke is a national stroke registry and quality improvement program. We examined the accuracy and reliability of data entered in GWTG-Stroke...
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failureAdrian F Hernandez
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
JAMA 303:1716-22. 2010..However, there are limited data describing patterns of follow-up after heart failure hospitalization and its association with readmission rates...
Left ventricular assist device destination therapy versus extended criteria cardiac transplantMani A Daneshmand
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
Ann Thorac Surg 89:1205-9; discussion 1210. 2010..The purpose of this study was to compare baseline characteristics and outcomes after EC-AL versus DT-LVAD...
Representativeness of a national heart failure quality-of-care registry: comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patientsLesley H Curtis
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Circ Cardiovasc Qual Outcomes 2:377-84. 2009..Participation in clinical registries is nonrandom, so participants may differ in important ways from nonparticipants. The extent to which findings from clinical registries can be generalized to broader populations is unclear...
Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD)Hector M Medina
Cardiac MR, PET, CT Program, Department of Radiology, Division of Cardiology, Massachusetts General Hospital, Boston, USA
Am Heart J 162:283-290.e2. 2011..To determine the adherence to national guidelines and in-hospital mortality of older patients with acute myocardial infarction (AMI) using a national database...
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007Kathleen T Unroe
Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Intern Med 171:196-203. 2011..Heart failure is a common cause of death among Medicare beneficiaries, but little is known about health care resource use at the end of life...
Use of cardiac resynchronization therapy in patients hospitalized with heart failureJonathan P Piccini
Duke Clinical Research Institute, Durham, NC 27715, USA
Circulation 118:926-33. 2008....
Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program studyUptal D Patel
Division of Nephrology, Duke University Medical Center, Durham, NC, USA
Am Heart J 156:674-81. 2008..Both heart failure (HF) and chronic kidney disease (CKD) are highly prevalent conditions that often coexist; however, the quality of care received by hospitalized patients with both is not known...
Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registryBimal Shah
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA
J Am Coll Cardiol 53:416-22. 2009..The aim of this study was to describe hospital variation and factors associated with adherence to guidelines for implantable cardioverter-defibrillator (ICD) therapy...
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007Jonathan P Piccini
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Circ Cardiovasc Qual Outcomes 5:85-93. 2012..The frequency of AF increases with age, but representative national data about incidence and prevalence are limited. We examined the annual incidence, prevalence, and mortality associated with AF among older persons...
Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practiceZubin J Eapen
Duke Clinical Research Institute, Durham, NC 27715, USA
Am Heart J 162:222-31. 2011..This article summarizes the discussions held at this meeting...
Infectious complications in extended criteria heart transplantationKeshava Rajagopal
Department of Surgery, Division of Thoracic Surgery, Duke University Medical Center, Durham, North Carolina, USA
J Heart Lung Transplant 27:1217-21. 2008..We hypothesized that other adverse outcomes, principally determined by recipient characteristics, occur at a higher rate in extended criteria recipients...
Implantable left ventricular assist devices: new hope for patients with end-stage heart failureCarmelo A Milano
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
N C Med J 67:110-5. 2006..Recently, the Food and Drug Administration approved implantable left ventricular assist devices (LVAD) as destination therapy (DT) for end-stage heart failure patients who are ineligible for cardiac transplantation...
Linking inpatient clinical registry data to Medicare claims data using indirect identifiersBradley G Hammill
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Am Heart J 157:995-1000. 2009..We present a method to link hospitalization records from registries with Medicare inpatient claims data, without using direct identifiers, to create a unique data source that pairs rich clinical data with long-term outcome data...
Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiariesRobb D Kociol
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Am Heart J 160:885-92. 2010..Clinical registries are used increasingly to analyze quality and outcomes, but the generalizability of findings from registries is unclear...
Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failureKevin L Thomas
Duke Clinical Research, Durham, NC, USA
Am Heart J 161:746-54. 2011..Yet, there have been insufficient data characterizing the clinical presentation, quality of care, and outcomes of patients hospitalized with HF as a function of race/ethnicity...
Regional differences in quality of care and outcomes for the treatment of acute coronary syndromes: an analysis from the get with the guidelines coronary artery disease programWarren Laskey
Division of Cardiology, Department of Internal Medicine, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131, USA
Crit Pathw Cardiol 9:1-7. 2010..The effect of hospital participation in a national performance improvement program on regional variation in quality of care and in-hospital outcomes for acute coronary syndromes (ACS) is unknown...
The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomesTracy Y Wang
Department of Medicine, Duke Clinical Research Institute, Durham, North Carolina 27705, USA
Arch Intern Med 169:1411-9. 2009..However, DTB time is only one of several important AMI care processes. It is unclear whether quality efforts targeted to a single process will facilitate concomitant improvement in other quality measures and outcomes...
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) RegistryAdrian F Hernandez
Duke Clinical Research Institute, Durham, NC 27715, USA
J Am Coll Cardiol 53:184-92. 2009..We sought to examine associations between initiation of beta-blocker therapy and outcomes among elderly patients hospitalized for heart failure...
Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005Sana M Al-Khatib
Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA
Circ Arrhythm Electrophysiol 1:240-9. 2008..We examined patient and implanting physician factors associated with outcomes of ICD therapy in Medicare beneficiaries from 2002 through 2005...
Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic SurgeonsAdrian F Hernandez
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Am Heart J 158:47-52. 2009..The appropriate use of vasoactive cardiovascular drugs in high-risk coronary artery bypass grafting (CABG) patients has not been well characterized...
Sex differences in medical care and early death after acute myocardial infarctionHani Jneid
Division of Cardiology, Michael E DeBakey VA Medical Center and Baylor College of Medicine, 2002 Holcombe Blvd, Houston, TX 77030, USA
Circulation 118:2803-10. 2008..It is unclear whether efforts undertaken to improve AMI care have mitigated these sex disparities in the current era...
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)Adrian F Hernandez
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
Am Heart J 157:271-7. 2009..However, the effect of nesiritide on dyspnea at 6 or 24 hours is unknown, and no clinical outcome trials have been done to provide a reliable estimate of the effect of nesiritide on morbidity and mortality...
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler
Department of Medicine, Division of Cardiology, Emory University, Atlanta, GA, USA
J Card Fail 18:265-81. 2012..The efficacy of eplerenone in patients with mild HF symptoms translates into a unique opportunity to reduce morbidity and mortality earlier in the course of the disease...
Outcomes Associated With Warfarin Use in Older Patients With Heart Failure and Atrial Fibrillation and a Cardiovascular Implantable Electronic Device: Findings From the ADHERE Registry Linked to Medicare ClaimsPaul L Hess
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina Department of Medicine, Duke University School of Medicine, Durham, North Carolina
Clin Cardiol 35:649-57. 2012..Warfarin use and associated outcomes in patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device have not been described previously...
Recurrence of cardiac sarcoidosis in a heart transplant recipientJonathan E E Yager
Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA
J Heart Lung Transplant 24:1988-90. 2005..He subsequently underwent uncomplicated heart transplantation. Nineteen months later, a routine surveillance endomyocardial biopsy specimen demonstrated recurrence of sarcoidosis in the transplanted heart...
Systematic review of the incidence of sudden cardiac death in the United StatesMelissa H Kong
Duke Clinical Research Institute, Durham, North Carolina, USA
J Am Coll Cardiol 57:794-801. 2011..S. population...
Early and long-term outcomes of heart failure in elderly persons, 2001-2005Lesley H Curtis
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Intern Med 168:2481-8. 2008..The treatment of chronic heart failure has improved during the past 2 decades, but little is known about whether the improvements are reflected in trends in early and long-term mortality and hospital readmission...
Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failureUptal D Patel
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Am Heart J 160:132-138.e1. 2010..We examined associations between WRF and 30-day readmission, mortality, and costs among Medicare beneficiaries hospitalized with heart failure...
Impact of heart failure on patients undergoing major noncardiac surgeryBradley G Hammill
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, North Carolina, USA
Anesthesiology 108:559-67. 2008..The authors evaluated short-term outcomes among patients with heart failure, coronary artery disease (CAD), or neither who underwent major noncardiac surgery...
Impact of left ventricular assist device bridging on posttransplant outcomesJay D Pal
Division of Thoracic Surgery, Duke University Medical Center, Durham, North Carolina 27705, USA
Ann Thorac Surg 88:1457-61; discussion 1461. 2009..However, referral for LVAD therapy may be limited secondary to reports of poor outcomes when mechanical circulatory support is required before transplantation...
Process of care performance measures and long-term outcomes in patients hospitalized with heart failureMark E Patterson
Center for Clinical and Genetic Economics, Duke University School of Medicine, Durham, NC, USA
Med Care 48:210-6. 2010..Recent efforts to improve care for patients hospitalized with heart failure have focused on process-based performance measures. Data supporting the link between current process measures and patient outcomes are sparse...
Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease programSamip Vasaiwala
Division of Cardiology, Brigham and Women s Hospital, Boston, Massachusetts, USA
Clin Cardiol 35:541-7. 2012..We studied the impact of chronic renal insufficiency on mortality and quality of inpatient care for AMI from the American Heart Association's Get With The Guidelines-Coronary Artery Disease Program...
Incidence and prevalence of heart failure in elderly persons, 1994-2003Lesley H Curtis
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Intern Med 168:418-24. 2008..We sought to estimate the annual incidence and prevalence of heart failure and associated survival in elderly persons from January 1, 1994, through December 31, 2003...
Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromesKyla M Bennett
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
Am J Cardiol 99:1351-6. 2007..Guideline-recommended therapies and interventions are under-utilized in patients with NSTE ACS and HF, with and without preserved systolic function, compared with those without HF...
Association of patient case-mix adjustment, hospital process performance rankings, and eligibility for financial incentivesRajendra H Mehta
Duke Clinical Research Institute and Duke University Medical Center, Durham, North Carolina 27715, USA
JAMA 300:1897-903. 2008..While most comparisons of hospital outcomes adjust for patient characteristics, process performance comparisons typically do not...
Hospital-level variation in mortality and rehospitalization for medicare beneficiaries with acute ischemic strokeGregg C Fonarow
Division of Cardiology, University of California, Los Angeles, CA, USA
Stroke 42:159-66. 2011..However, little is known regarding contemporary ischemic stroke mortality and rehospitalization rates for Medicare beneficiaries and how they vary by hospital...
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failureAdrian F Hernandez
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
JAMA 298:1525-32. 2007..The influence of sex and race on ICD use among eligible patients is unknown...
A review of dyspnea in acute heart failure syndromesRyenn L West
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Am Heart J 160:209-14. 2010....
End points for clinical trials in acute heart failure syndromesLarry A Allen
Division of Cardiology, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
J Am Coll Cardiol 53:2248-58. 2009....
Do heart failure disease management programs make financial sense under a bundled payment system?Zubin J Eapen
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
Am Heart J 161:916-22. 2011..Whether a bundled payment approach can address the negative financial impact of DM programs is unknown...
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines programRajendra H Mehta
Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, USA
Am Heart J 155:1059-67. 2008..Although preferably D2B times should be <or=90 minutes, it is unclear how consistently this is achieved in community practice, particularly in women, elderly people, and minorities...
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapiesMelissa H Kong
Duke Clinical Research Institute, Durham, NC, USA
Am Heart J 160:605-18. 2010..This article summarizes the discussions that occurred at the meeting...
Topical anesthesia with EMLA reduces pain during endomyocardial biopsy: a randomized trialDianne H Leloudis
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina
J Heart Lung Transplant 25:1164-6. 2006..A better understanding of the factors affecting pain during EMBx could improve the comfort level of this procedure...
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery diseaseNancy M Allen LaPointe
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
Am J Cardiol 103:1518-24. 2009..We were unable to demonstrate a statistically significant association between persistent ACEI/ARB use and survival...
Efficacy and safety of nesiritide in patients with acute decompensated heart failureTracy A Dewald
Division of Clinical Pharmacology, Duke University Medical Center, Box 3943 Medical Center, Durham, NC 27710, USA
Expert Rev Cardiovasc Ther 8:159-69. 2010..However, the pathophysiology of acute decompensated heart failure is complex and the impact of nesiritide on important clinical end points, beyond symptomatic and hemodynamic improvement, is unknown...
Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac deathLesley H Curtis
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
JAMA 298:1517-24. 2007..Previous studies of sex differences in the use of implantable cardioverter-defibrillators (ICDs) predate recent expansions in Medicare coverage and did not provide patient follow-up over multiple years...
Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trialsG Michael Felker
Duke Clinical Research Institute and the Division of Cardiology, Duke University Medical Center, Durham, NC 27705, USA
Am Heart J 158:422-30. 2009..We performed a quantitative meta-analysis of available randomized controlled trials to determine whether titration of therapy based on natriuretic peptide measurements improves mortality in chronic heart failure...
Comparative effectiveness of angiotensin-converting-enzyme inhibitors: is an ACE always an ace?Adrian F Hernandez
Duke Clinical Research Institute and the Division of Cardiovascular Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA
CMAJ 178:1316-9. 2008
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) TrialSunil V Rao
Duke Clinical Research Institute, Durham, NC, USA
Circulation 121:1713-21. 2010..We performed a phase 2 randomized trial to evaluate the safety and feasibility of M118 in the setting of elective percutaneous coronary intervention...
Outcomes with an alternate list strategy for heart transplantationG Michael Felker
Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA
J Heart Lung Transplant 24:1781-6. 2005..The creation of an alternate list to match recipients with contraindications to traditional HT with sub-optimal donor organs has been implemented at some centers, but outcomes using this approach are uncertain...
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker
Duke University School of Medicine and Duke Heart Center, Durham, NC, USA
N Engl J Med 364:797-805. 2011..Loop diuretics are an essential component of therapy for patients with acute decompensated heart failure, but there are few prospective data to guide their use...
Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devicesJorge Suarez
Duke Clinical Research Institute and the Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA
Circ Heart Fail 4:779-84. 2011....
Preoperative evaluation for major noncardiac surgery: focusing on heart failureAdrian F Hernandez
Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27710, USA
Arch Intern Med 164:1729-36. 2004..This review will summarize preoperative assessment and perioperative management with an emphasis on heart failure...
Translating evidence into practice: use of statins in real-world patients with heart failureAdrian F Hernandez
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Heart Fail Clin 4:217-23. 2008..This article reviews the conceptual basis for driving evidence-based medicine by focusing on quality of care for heart failure patients...
Combination of loop diuretics with thiazide-type diuretics in heart failureJacob C Jentzer
Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA
J Am Coll Cardiol 56:1527-34. 2010..We provide considerations about prudent use of this therapy and review potential misconceptions about this long-used diuretic approach. Finally, we seek to highlight the need for pragmatic clinical trials for this commonly used therapy...
Left ventricular assessment in myocardial infarction: the VALIANT registryAdrian F Hernandez
Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Intern Med 165:2162-9. 2005..41; P<.001). CONCLUSION: Left ventricular assessment was frequently not performed during the in-hospital stay of patients with acute MI, including those with clinical HF, and its use was associated with better quality of care...
Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines databaseBenjamin A Steinberg
Johns Hopkins School of Medicine, Baltimore, MD, USA
Am J Cardiol 100:1331-5. 2007..In conclusion, increasing BMI appears to be associated with better use of guideline-recommended medical treatment and invasive management of CAD, which may explain the observed lower rates of in-hospital mortality...
Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database)Sumit Tickoo
Cardiology Division, Danbury Hospital, Danbury, Connecticut, USA
Am J Cardiol 102:663-7. 2008..However, there remain further opportunities to improve utilization of guideline-recommended therapies irrespective of discharge day...
Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromesBrett D Atwater
University of Wisconsin Madison, Madison, Wisconsin, USA
Am J Cardiol 100:1727-33. 2007..In conclusion, more widespread measurement of BNP levels for risk stratification of patients with NSTE ACS may be warranted...
